首页> 外文期刊>Research and practice in thrombosis and haemostasis. >Risk scores for occult cancer in patients with unprovoked venous thromboembolism: Results from an individual patient data meta‐analysis
【24h】

Risk scores for occult cancer in patients with unprovoked venous thromboembolism: Results from an individual patient data meta‐analysis

机译:患有未加产静脉血栓栓塞患者的隐匿性癌症的风险评分:各个患者数据META分析的结果

获取原文
       

摘要

Background The Registro Informatizado de Pacientes con Enfermedad TromboEmbólica (RIETE) score and the Screening for Occult Malignancy in Patients with Idiopathic Venous Thromboembolism (SOME) risk scores aim to identify patients with acute unprovoked venous thromboembolism (VTE) at high risk of occult cancer, but their predictive performance is unclear. Methods The scores were evaluated in an individual patient data meta‐analysis. Studies were eligible if enrolling consecutive adults with unprovoked VTE who underwent protocol‐mandated screening for cancer. The primary outcome was a cancer diagnosis between 30?days and 2?years of follow‐up. The discriminatory performance was evaluated by computing the area under the receiver (ROC) curve in random‐effects meta‐analyses. Results The RIETE score could be calculated in 1753 patients, of whom 63 (3.6%) were diagnosed with cancer. The pooled area under the ROC curve was 0.59 (95% confidence interval [CI], 0.52‐0.66; I 2 =?0%). Of the 427 patients (24%) classified as high risk, 25 (5.9%) were diagnosed with cancer compared with 38 of 1326 (2.9%) low‐risk patients (hazard ratio [HR], 2.0; 95% CI, 1.3‐3.4). The SOME score was calculated in 925 patients, of whom 37 (4.0%) were diagnosed with cancer. The pooled area under the ROC curve was 0.56 (95% CI, 0.46‐0.65; I 2 =?46%). Of the 161 patients (17%) classified as high risk (≥2 points), eight (5.0%) were diagnosed with cancer compared with 29 of 764 (3.8%) low‐risk patients (HR, 1.2; 95% CI, 0.55‐2.7). Conclusions The predictive discriminatory performance of both scores is poor. When used dichotomously, the RIETE score is able to discriminate between low‐ and high‐risk patients. Because this is largely driven by advanced age, these results do not support the use of these scores in daily clinical practice.
机译:背景技术Registrane Informatizodo de Pacientes Con EnfermedadTromboembólica(Riete)得分和潜水恶性肿瘤患者的筛查患者在特发性静脉血栓栓塞(某些)风险分数旨在识别患有急性未加工的静脉血栓栓塞(VTE)的患者,高危癌症的高危癌症,但是他们的预测性能尚不清楚。方法在个体患者数据META分析中评估评分。如果招募连续成年人,研究有资格有资格,其中包含未加工的vte,涉及癌症的议定书筛查。主要结果是癌症诊断30?天和2年的后续行动。通过计算随机效应元分析中的接收器(ROC)曲线下的区域来评估歧视性能。结果Riete评分可以在1753名患者中计算,其中63例(3.6%)被诊断为癌症。 ROC曲线下的汇集区域为0.59(95%置信区间[CI],0.52-0.66; I 2 = 0%)。在427名患者中(24%)分类为高风险,25%(5.9%)被诊断为癌症,而1326名(2.9%)低风险患者(危害比[HR],2.0; 95%CI,1.3- 3.4)。在925名患者中计算了一些得分,其中37名(4.0%)被诊断出癌症。 ROC曲线下的汇集区域为0.56(95%CI,0.46-0.65; I 2 = 46%)。在161名患者中(17%)分类为高风险(≥2分),八(5.0%)被诊断为癌症,而764(3.8%)低风险患者(HR,1.2; 95%CI,0.55 -2.7)。结论两个分数的预测歧视性能差。当用二分法时,RIETE评分能够区分低风险和高风险的患者。因为这在很大程度上受到高级年龄的推动,这些结果不支持在日常临床实践中使用这些评分。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号